Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.
Evercore ISI Group Initiates Coverage On ProKidney with Outperform Rating
Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.
Related Posts
Super Micro Computer Sees ‘Fundamental Shift,’ Analyst Praises Generative AI Investments
August 23, 12:33 PM
Super Micro Computer Inc (NASDAQ: SMCI) reported better-than-expected earnings for the fiscal fourth quarter (Q4) earlier this month and received a fo
Citigroup Maintains Buy on Apple, Lowers Price Target to $175
October 28, 6:35 AM
Citigroup analyst Jim Suva maintains Apple (NASDAQ:AAPL) with a Buy and lowers the price target from $185 to $175.
Germany Sets THC Limits For Drivers, Opposition Groups Say It’s Too High
June 7, 11:22 AM
Lawmakers in Germany have set a maximum allowed limit of THC – tetrahydrocannabinol, a psychoactive substance found in the cannabis plant- for drivers to have in the blood. The Bundestag, the country's lower house of parliament, introduced this week a limit of 3.5 nanograms per milliliter. As DW highlighted that's an equivalent to 20 milligrams of alcohol per 100 milliliters of blood. The decision builds on a recommendation by an expert panel commissioned by the Transport Ministry.